J Acquir Immune Defic Syndr Hum Retrovirol 1996, 11:419–429

J Acquir Immune Defic Syndr Hum Retrovirol 1996, 11:419–429.PubMedCrossRef 22. Rey MW, Woloshuk SL, deBoer HA, Nirogacestat Pieper FR: Complete nucleotide sequence of human mammary gland lactoferrin. Nucleic Acids Res 1990, 18:5288.PubMedCrossRef 23. Powell MJ, Ogden JE: Nucleotide sequence of human lactoferrin cDNA. Nucleic Acids Res 1990, 18:4013.PubMedCrossRef 24. Lin TY, Chu C, Chiu CH: Lactoferrin inhibits enterovirus 71 infection of human embryonal

rhabdomyosarcoma cells in vitro. J Infect Dis 2002, 186:1161–1164.PubMedCrossRef 25. Weng TY, Chen LC, Shyu HW, Chen SH, Wang JR, Yu CK, Lei HY, Yeh TM: Lactoferrin inhibits enterovirus 71 infection by binding to VP1 protein and host cells. Antiviral Res 2005, 67:31–37.PubMedCrossRef 26. Alexander DA, Dimock K: Sialic acid functions in enterovirus 70 binding and infection. J Virol 2002, 76:11265–11272.PubMedCrossRef 27. Nilsson EC, Jamshidi F, Johansson SM, Oberste MS, Arnberg N: Sialic acid is a cellular receptor for coxsackievirus A24 variant, an emerging virus with pandemic potential. J Virol 2008, 82:3061–3068.PubMedCrossRef 28. Lehmann F, Tiralongo E, Tiralongo J: Sialic acid-specific lectins: occurrence, specificity and function. Cell Mol Life

Sci 2006, 63:1331–1354.PubMedCrossRef 29. Yang B, Chuang H, Yang KD: Sialylated glycans as receptor and inhibitor of enterovirus 71 infection to DLD-1 intestinal cells. Virol J 2009, 6:141.PubMedCrossRef 30. Chang CF, Pan JF, Lin CN, Wu IL, Wong CH, Lin CH: Rapid Stattic clinical trial Dapagliflozin characterization of sugar-binding specificity by in-solution proximity binding with photosensitizers. Glycobiology 2011, 21:895–902.PubMedCrossRef 31. Kansas GS: Selectins and their ligands: current concepts and controversies. Blood 1996, 88:3259–3287.PubMed 32. Geijtenbeek TB, Torensma R, van Vliet SJ, van Duijnhoven GC, Adema GJ, van Kooyk Y, Figdor CG: Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell 2000, 100:575–585.PubMedCrossRef 33. Skehel JJ, Wiley

DC: Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu Rev Biochem 2000, 69:531–569.PubMedCrossRef 34. Sheu BS, Odenbreit S, Hung KH, Liu CP, Sheu SM, Yang HB, Wu JJ: Interaction between host gastric Sialyl-Lewis X and H. pylori SabA enhances H. pylori density in patients lacking gastric Lewis B antigen. Am J Gastroenterol 2006, 101:36–44.PubMedCrossRef 35. Heyningen SV: Cholera toxin: interaction of subunits with MDV3100 order ganglioside GM1. Science 1974, 183:656–657.CrossRef 36. Matrosovich MN, Gambaryan AS, Teneberg S, Piskarev VE, Yamnikova SS, Lvov DK, Robertson JS, Karlsson KA: Avian influenza A viruses differ from human viruses by recognition of sialyloligosaccharides and gangliosides and by a higher conservation of the HA receptor-binding site. Virology 1997, 233:224–234.PubMedCrossRef 37.

Comments are closed.